Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sj ögren syndrome
ConclusionsHCQ reduced the incidence of DM in a time and dose-dependent manner. Patients with SS who had taken HCQ for 3 years or more exhibited significant protective effects against developing new-onset DM.
Source: QJM - Category: Internal Medicine Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Mellitus | Endocrinology | Health Insurance | Hydroxychloroquine | Insurance | Internal Medicine | Study | Taiwan Health